We have located links that may give you full text access.
JOURNAL ARTICLE
REVIEW
Multimodal imaging of diabetic retinopathy.
Current Opinion in Ophthalmology 2018 November
PURPOSE OF REVIEW: Diabetic retinopathy is the most common microvascular complication of diabetes mellitus and a leading cause of blindness throughout the world. Ocular imaging continues to play a vital role in the diagnosis, management and monitoring of diabetic retinopathy. Major technological advancements in imaging over the past decade have improved our understanding and knowledge of diabetic retinopathy and therefore a multimodal approach to imaging has become the standard of care.
RECENT FINDINGS: Updates to traditional technologies such as digital fundus photography along with recent advancements in optical coherence tomography (OCT) and OCT angiography (OCTA) have provided clinicians with new information and improved efficiency.
SUMMARY: In this review, we describe the benefits and clinical applications of several imaging techniques in diabetic retinopathy including color photography, fluorescein angiography, OCT, OCTA and adaptive optics. Understanding the indications and limitations of each technology allows clinicians to gain the most information from each modality and thereby optimize patient care.
RECENT FINDINGS: Updates to traditional technologies such as digital fundus photography along with recent advancements in optical coherence tomography (OCT) and OCT angiography (OCTA) have provided clinicians with new information and improved efficiency.
SUMMARY: In this review, we describe the benefits and clinical applications of several imaging techniques in diabetic retinopathy including color photography, fluorescein angiography, OCT, OCTA and adaptive optics. Understanding the indications and limitations of each technology allows clinicians to gain the most information from each modality and thereby optimize patient care.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app